These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 37104426)
1. Clinical Effects of Faecal Microbiota Transplantation as Adjunctive Therapy in Dogs with Chronic Enteropathies-A Retrospective Case Series of 41 Dogs. Toresson L; Spillmann T; Pilla R; Ludvigsson U; Hellgren J; Olmedal G; Suchodolski JS Vet Sci; 2023 Apr; 10(4):. PubMed ID: 37104426 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal assessment of microbial dysbiosis, fecal unconjugated bile acid concentrations, and disease activity in dogs with steroid-responsive chronic inflammatory enteropathy. Guard BC; Honneffer JB; Jergens AE; Jonika MM; Toresson L; Lawrence YA; Webb CB; Hill S; Lidbury JA; Steiner JM; Suchodolski JS J Vet Intern Med; 2019 May; 33(3):1295-1305. PubMed ID: 30957301 [TBL] [Abstract][Full Text] [Related]
3. Machine Learning and Canine Chronic Enteropathies: A New Approach to Investigate FMT Effects. Innocente G; Patuzzi I; Furlanello T; Di Camillo B; Bargelloni L; Giron MC; Facchin S; Savarino E; Azzolin M; Simionati B Vet Sci; 2022 Sep; 9(9):. PubMed ID: 36136718 [TBL] [Abstract][Full Text] [Related]
4. Faecal microbiome transplantation improves clinical signs of chronic idiopathic large bowel diarrhoea in working dogs. Alves JC; Santos A; Jorge P; Pitães  Vet Rec; 2023 Nov; 193(10):e3052. PubMed ID: 37245211 [TBL] [Abstract][Full Text] [Related]
5. Faecal Microbiome Transplantation as a Solution to Chronic Enteropathies in Dogs: A Case Study of Beneficial Microbial Evolution. Berlanda M; Innocente G; Simionati B; Di Camillo B; Facchin S; Giron MC; Savarino E; Sebastiani F; Fiorio F; Patuzzi I Animals (Basel); 2021 May; 11(5):. PubMed ID: 34067662 [TBL] [Abstract][Full Text] [Related]
6. Investigation of the efficacy of a dietetic food in the management of chronic enteropathies in dogs. Tørnqvist-Johnsen C; Campbell S; Gow A; Bommer NX; Salavati S; Mellanby RJ Vet Rec; 2020 Jan; 186(1):26. PubMed ID: 31662575 [TBL] [Abstract][Full Text] [Related]
7. The characteristics of short- and long-term surviving Shiba dogs with chronic enteropathies and the risk factors for poor outcome. Okanishi H; Sano T; Yamaya Y; Kagawa Y; Watari T Acta Vet Scand; 2013 Apr; 55(1):32. PubMed ID: 23594569 [TBL] [Abstract][Full Text] [Related]
8. Fecal Microbial and Metabolic Profiles in Dogs With Acute Diarrhea Receiving Either Fecal Microbiota Transplantation or Oral Metronidazole. Chaitman J; Ziese AL; Pilla R; Minamoto Y; Blake AB; Guard BC; Isaiah A; Lidbury JA; Steiner JM; Unterer S; Suchodolski JS Front Vet Sci; 2020; 7():192. PubMed ID: 32363202 [TBL] [Abstract][Full Text] [Related]
10. Successful outcome after a single endoscopic fecal microbiota transplantation in a Shiba dog with non-responsive enteropathy during the treatment with chlorambucil. Sugita K; Shima A; Takahashi K; Matsuda Y; Miyajima M; Hirokawa M; Kondo H; Kimura J; Ishihara G; Ohmori K J Vet Med Sci; 2021 Jul; 83(6):984-989. PubMed ID: 33896875 [TBL] [Abstract][Full Text] [Related]
11. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease]. Münster M; Hörauf A; Bilzer T Berl Munch Tierarztl Wochenschr; 2006; 119(11-12):493-505. PubMed ID: 17172138 [TBL] [Abstract][Full Text] [Related]
12. Observational Study of Small Animal Practitioners' Awareness, Clinical Practice and Experience With Fecal Microbiota Transplantation in Dogs. Salavati Schmitz S Top Companion Anim Med; 2022; 47():100630. PubMed ID: 35021112 [TBL] [Abstract][Full Text] [Related]
13. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome. El-Salhy M; Casen C; Valeur J; Hausken T; Hatlebakk JG World J Gastroenterol; 2021 May; 27(18):2219-2237. PubMed ID: 34025075 [TBL] [Abstract][Full Text] [Related]
14. Investigating fecal microbial transplant as a novel therapy in dogs with inflammatory bowel disease: A preliminary study. Collier AJ; Gomez DE; Monteith G; Plattner BL; Verbrugghe A; Webb J; Weese JS; Blois SL PLoS One; 2022; 17(10):e0276295. PubMed ID: 36256653 [TBL] [Abstract][Full Text] [Related]
15. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience. Pipek B; Valentová H; Fojtík P; Urban O Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450 [TBL] [Abstract][Full Text] [Related]
16. Clinical results and microbiota changes after faecal microbiota transplantation for chronic pouchitis: a pilot study. Kousgaard SJ; Michaelsen TY; Nielsen HL; Kirk KF; Brandt J; Albertsen M; Thorlacius-Ussing O Scand J Gastroenterol; 2020 Apr; 55(4):421-429. PubMed ID: 32285709 [No Abstract] [Full Text] [Related]
17. Faecal proteomics in the identification of biomarkers to differentiate canine chronic enteropathies. O'Reilly EL; Horvatić A; Kuleš J; Gelemanović A; Mrljak V; Huang Y; Brady N; Chadwick CC; Eckersall PD; Ridyard A J Proteomics; 2022 Mar; 254():104452. PubMed ID: 34958965 [TBL] [Abstract][Full Text] [Related]
18. Urinary and faecal N-methylhistamine concentrations do not serve as markers for mast cell activation or clinical disease activity in dogs with chronic enteropathies. Anfinsen KP; Berghoff N; Priestnall SL; Suchodolski JS; Steiner JM; Allenspach K Acta Vet Scand; 2014 Dec; 56(1):90. PubMed ID: 25528646 [TBL] [Abstract][Full Text] [Related]
19. A randomized, open-label, positively-controlled field trial of a hydrolyzed protein diet in dogs with chronic small bowel enteropathy. Mandigers PJ; Biourge V; van den Ingh TS; Ankringa N; German AJ J Vet Intern Med; 2010; 24(6):1350-7. PubMed ID: 21054541 [TBL] [Abstract][Full Text] [Related]
20. Identification of matrix metalloproteinase-2 and -9 activities within the intestinal mucosa of dogs with chronic enteropathies. Hanifeh M; Rajamäki MM; Syrjä P; Mäkitalo L; Kilpinen S; Spillmann T Acta Vet Scand; 2018 Mar; 60(1):16. PubMed ID: 29530095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]